vampwatching vs Kazuya | 53–27 | 66.25% |
vampwatching vs Reina | 26–15 | 63.41% |
vampwatching vs Jin | 24–16 | 60.00% |
vampwatching vs Dragunov | 15–16 | 48.39% |
vampwatching vs Paul | 19–11 | 63.33% |
vampwatching vs Hwoarang | 15–14 | 51.72% |
vampwatching vs Law | 8–18 | 30.77% |
vampwatching vs Bryan | 14–12 | 53.85% |
vampwatching vs Yoshimitsu | 13–11 | 54.17% |
vampwatching vs Lili | 12–10 | 54.55% |
vampwatching vs Nina | 12–9 | 57.14% |
vampwatching vs Devil Jin | 11–7 | 61.11% |
vampwatching vs King | 11–6 | 64.71% |
vampwatching vs Jun | 9–7 | 56.25% |
vampwatching vs Xiaoyu | 11–4 | 73.33% |
vampwatching vs Steve | 10–5 | 66.67% |
vampwatching vs Claudio | 6–8–1 | 42.86% |
vampwatching vs Asuka | 9–5 | 64.29% |
vampwatching vs Feng | 10–4 | 71.43% |
vampwatching vs Azucena | 10–4 | 71.43% |
vampwatching vs Lee | 6–7 | 46.15% |
vampwatching vs Eddy | 4–9 | 30.77% |
vampwatching vs Panda | 5–3 | 62.50% |
vampwatching vs Victor | 1–7 | 12.50% |
vampwatching vs Leo | 2–5 | 28.57% |
vampwatching vs Zafina | 2–5 | 28.57% |
vampwatching vs Clive | 3–4 | 42.86% |
vampwatching vs Lars | 3–3 | 50.00% |
vampwatching vs Shaheen | 3–2 | 60.00% |
vampwatching vs Jack-8 | 4–0 | 100.00% |
vampwatching vs Alisa | 4–0 | 100.00% |
vampwatching vs Kuma | 2–1 | 66.67% |
vampwatching vs Heihachi | 1–2 | 33.33% |
vampwatching vs Leroy | 1–0 | 100.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.